DRREDDY's weekly performance was disappointing, with a return of -1.14%, underperforming its peers. The stock's high volatility of 17.06% contributed to its poor performance, resulting in a Sharpe Ratio of -0.26, indicating a high level of risk. Compared to its peers, DRREDDY underperformed DIVISLAB and HINDUNILVR, but outperformed SUNPHARMA. Overall, the stock's high volatility and negative return make it a risky investment this week.

[Volatility: 17.06%]